Dayton Therapeutics ^Company

Dayton Therapeutics is a clinical oncology company that focuses on identifying compounds for treating cancer indications with limited therapeutic options. They have identified satraplatin as having a significant effect in haemato-oncology indications and are developing it as a precision platinum for orphan lymphomas. The company uses proprietary oncologist know-how amplified by AI and data mining to systematically pursue high-yield candidates for cancer indications of large unmet medical need.